Arkadios Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$592K Sell
1,118
-103
-8% -$47.5K 0.01% 1054
2026
Q1
$586K Buy
1,221
+406
+50% +$208K 0.01% 1034
2025
Q4
$458K Sell
815
-58
-7% -$32.9K 0.01% 1058
2025
Q3
$449K Sell
873
-170
-16% -$74.2K 0.01% 980
2025
Q2
$327K Buy
+1,043
New +$313K 0.01% 1023
2024
Q1
Sell
-2,178
Closed -$668K 767
2023
Q4
$668K Buy
2,178
+18
+0.8% +$4.86K 0.06% 300
2023
Q3
$523K Buy
2,160
+25
+1% +$6.39K 0.05% 323
2023
Q2
$513K Hold
2,135
0.06% 300
2023
Q1
$401K Buy
+2,135
New +$442K 0.05% 357

Other funds holding MEDP

Arkadios Wealth Advisors's MEDP Position: Q2 2026 in Review

Arkadios Wealth Advisors reduced its Medpace (MEDP) stake by 8.4% in Q2 2026, selling an estimated $47.5K and leaving 1,118 shares worth $592K. The position accounts for 0.01% of the portfolio, ranked #1054.

Arkadios Wealth Advisors first reported a position in MEDP in Q1 2023 and has held it in 9 quarters since. The position peaked at $668K in Q4 2023. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Arkadios Wealth Advisors held 1,118 shares of Medpace worth $592K as of Q2 2026.
  • Arkadios Wealth Advisors sold 103 Medpace shares in Q2 2026, an estimated $47.5K.
  • Medpace made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1054 holding.
  • Arkadios Wealth Advisors first reported a position in Medpace in Q1 2023 and has held it in 9 quarters since.
  • Arkadios Wealth Advisors's Medpace position peaked at $668K in Q4 2023.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.